GLOPTIC 20mg / 5mg / ml ophthalmic drops solution medication leaflet

S01ED51 dorzolamide + timolol • Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents

The combination of Dorzolamidum + Timololum is used for the treatment of glaucoma and ocular hypertension in patients who do not respond adequately to monotherapy. Dorzolamidum is a carbonic anhydrase inhibitor, and Timololum is a beta-blocker; together, they reduce intraocular pressure through complementary mechanisms.

The medication is available as eye drops and is usually administered twice daily, according to the doctor's instructions. It is effective in preventing optic nerve damage and preserving vision.

Side effects may include burning or stinging sensation in the eyes, bitter taste, dry eyes, fatigue, and, in rare cases, allergic reactions. Regular monitoring of intraocular pressure is essential.

Consult your doctor to discuss the benefits and risks of treatment with this combination. Follow the administration instructions to ensure treatment effectiveness.

General data about GLOPTIC 20mg / 5mg / ml

Substance: dorzolamide + timolol

Date of last drug list: 01-07-2020

Commercial code: W66724003

Concentration: 20mg / 5mg / ml

Pharmaceutical form: ophthalmic drops solution

Quantity: 6

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: PHARMATHEN S.A. - GRECIA

Holder: MYLAN IRELAND LIMITED - IRLANDA

Number: 11318/2018/03

Shelf life: 2 years-after packing for marketing; after the first opening-28 days

Pharmaceutical forms available for dorzolamide + timolol

Other substances similar to dorzolamide + timolol